Abstract
Only 10% of mutations in the Myelin Protein Zero (MPZ) gene are associated with Charcot-Marie-Tooth type 2 (CMT2) disease. The phenotype of CMT2 disease caused by mutations in the MPZ gene is usually characterized by late onset (over 4th decade), marked sensory disturbances, pupillary abnormalities and hearing loss (observed in some patients). MPZ gene analysis in AD CMT2 family basing upon clinical features. Neurological examination, electrophysiological study, audiometry and molecular genetic analysis of the MPZ gene.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
